Wells Fargo & Company MN Purchases 226,819 Shares of China Cord Blood Corp (CO)

Wells Fargo & Company MN raised its position in China Cord Blood Corp (NYSE:CO) by 1,260,105.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 226,837 shares of the medical research company’s stock after buying an additional 226,819 shares during the quarter. Wells Fargo & Company MN owned about 0.31% of China Cord Blood worth $2,522,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Trexquant Investment LP purchased a new stake in shares of China Cord Blood during the 3rd quarter worth $236,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of China Cord Blood during the 3rd quarter worth $944,000. Ameriprise Financial Inc. purchased a new stake in shares of China Cord Blood during the 3rd quarter worth $3,881,000. SG Americas Securities LLC boosted its position in shares of China Cord Blood by 131.2% during the 3rd quarter. SG Americas Securities LLC now owns 231,204 shares of the medical research company’s stock worth $2,571,000 after purchasing an additional 131,204 shares in the last quarter. Finally, Parametrica Management Ltd boosted its position in shares of China Cord Blood by 1,842.1% during the 3rd quarter. Parametrica Management Ltd now owns 304,903 shares of the medical research company’s stock worth $3,391,000 after purchasing an additional 289,203 shares in the last quarter. 9.12% of the stock is currently owned by institutional investors.

Shares of China Cord Blood Corp (CO) opened at $9.11 on Friday. The company has a market cap of $1,098.70, a price-to-earnings ratio of 26.03 and a beta of 0.88. China Cord Blood Corp has a 1 year low of $5.06 and a 1 year high of $14.95.

COPYRIGHT VIOLATION WARNING: “Wells Fargo & Company MN Purchases 226,819 Shares of China Cord Blood Corp (CO)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/14/wells-fargo-company-mn-purchases-226819-shares-of-china-cord-blood-corp-co.html.

China Cord Blood Profile

China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.

Institutional Ownership by Quarter for China Cord Blood (NYSE:CO)

Receive News & Ratings for China Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply